[1]郑维维,杜子琪,陈 怡,等.归肾丸加减联合T管治疗宫腔粘连术后疗效研究[J].陕西中医,2022,(12):1729-1733.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.018]
 ZHENG Weiwei,DU Ziqi,CHEN Yi,et al.Clinical efficacy study on modified Guishen Wan combined with T tube for postoperative intrauterine adhesions[J].,2022,(12):1729-1733.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.018]
点击复制

归肾丸加减联合T管治疗宫腔粘连术后疗效研究
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2022年12期
页码:
1729-1733
栏目:
临床研究
出版日期:
2022-12-20

文章信息/Info

Title:
Clinical efficacy study on modified Guishen Wan combined with T tube for postoperative intrauterine adhesions
作者:
郑维维1杜子琪1陈 怡1陈慕镟1廖慧慧2
(1.广州中医药大学,广东 广州510405; 2.广州中医药大学第一附属医院,广东 广州510405)
Author(s):
ZHENG WeiweiDU ZiqiCHEN YiCHEN MuxuanLIAO Huihui
(Guangzhou University of Traditional Chinese Medicine,Guangzhou 510405,China)
关键词:
宫腔粘连 归肾丸 T管治疗 子宫内膜 雌激素受体 雌孕激素序贯治疗
Keywords:
Intrauterine adhesion Guishen Wan T tube treatment Endometrium Estrogen receptor Estrin sequential treatment
分类号:
R 713.4
DOI:
DOI:10.3969/j.issn.1000-7369.2022.12.018
文献标志码:
A
摘要:
目的:观察归肾丸加减联合T管用于宫腔粘连术后的临床疗效及其对患者子宫内膜雌激素受体(ER)的影响。方法:回顾性分析92例确诊为中重度宫腔粘连并行宫腔镜下粘连松解术的患者,根据术后预防粘连措施的不同分为三组。观察组31例,T管治疗术后予以归肾丸; 西药组30例,T管治疗术后予以雌孕激素序贯治疗; 球囊组31例,术后予以雌孕激素序贯治疗联合Cook球囊。三组患者均治疗2个月经周期,观察治疗前后宫腔粘连评分、月经量、子宫内膜厚度、子宫内膜ER变化情况、妊娠情况等。结果:观察组总有效率为87.10%、西药组83.33%,球囊组80.65%,三组间总有效率比较,差异无统计学意义(P>0.05)。治疗后三组宫腔粘连评分均较治疗前下降,月经量积分、子宫内膜厚度、子宫内膜ER水平均较治疗前上升,差异有统计学意义(均P<0.05)。观察组与西药组在增加子宫内膜厚度方面均优于球囊组,差异有统计学意义(均P<0.05)。三组在提升月经量积分、子宫内膜ER水平、降低宫腔粘连评分方面比较,差异无统计学意义(均P>0.05)。治疗过程中三组均未出现药物过敏、子宫穿孔、感染等不良反应。结论:归肾丸加减联合T管治疗宫腔粘连术后患者,可有效预防粘连复发,增加月经量,促进子宫内膜增厚,提高子宫内膜ER水平,其总体疗效与雌孕激素序贯治疗联合球囊方案相当,且在增加子宫内膜厚度方面效果更优。
Abstract:
Objective:To observe clinical efficacy of modified Guishen Wan combined with T tube for postoperative intrauterine adhesion and its effect on endometrial estrogen receptor(ER).Methods:A retrospective analysis of 92 patients diagnosed with moderate to severe intrauterine adhesions underwent hysteroscopic adhesion anlysis was performed,divided into three groups according to different postoperative adhesion prevention measures.31 cases in the observation group were given modified Guishen Wan combined with T tube after operation,30 cases in the western medicine group received estrogen-progestin sequential therapy combined with T tube therapy after operation,31 cases in the balloon group received estrogen-progestin sequential therapy combined with Cook balloon therapy after operation.All the three groups were treated for 2 menstrual cycles.Before and after treatment,the intrauterine adhesion scores,menstrual flow scores,endometrial thickness,endometrial ER levels and pregnancy rate were observed.Results:The total efficiency of the observation group was 87.10%,the western medicine group 83.33%,the balloon group 80.65%,there was no significant difference in the three groups(P>0.05).After treatment,the intrauterine adhesion scores of the three groups were all significantly lower than before,and the menstrual flow scores,endometrial thickness,and endometrial ER levels of the three groups were all significantly higher than before,difference statistically significant(all P<0.05).After treatment,the intrauterine adhesion score of the three groups was decreased compared with that before treatment,the menstrual volume score,endometrial thickness and endometrial ER level were increased compared with those before treatment,differences statistically significant(all P<0.05).The observation group and the western medicine group in increasing endometrial thickness were better than those in the balloon group difference statistically significant(all P<0.05).Improving menstrual volume score,endometrial ER level and reducing uterine adhesion score among the three groups,no significant difference(all P>0.05).No adverse reactions such as drug allergy,uterine perforation and infection occurred in the three groups during the treatment.Conclusion:Guishen Wan combined with T tube in the treatment of patients after intrauterine adhesions can effectively prevent recurrence of adhesions,increase menstrual volume,promote endometrial thickening,and improve endometrial ER level.The overall efficacy of Guishen Wan combined with balloon therapy is comparable to that of progesterone sequential therapy combined with balloon therapy,effect better in increasing endometrial thickness.

参考文献/References:

[1] 段 华,甘 露.宫腔粘连诊治的现状与存在问题[J].实用妇产科杂志,2017,33(10):6-8.
[2] Magos A.Hysteroscopic treatment of Asherman's syndrome[J].Reproductive Biomedicine Online,2002,4(3):46-51.
[3] 段 华,夏恩兰.宫腔粘连临床诊疗中国专家共识[J].中华妇产科杂志,2015,50(12):881-887.
[4] 方 昉,廖慧慧.补肾活血法联合T管预防宫腔粘连术后复发的临床效果[J].广州中医药大学学报,2020,37(12):2331-2336.
[5] 国家中医药管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:384-388.
[6] 罗颂平,谭 勇.中医妇科学[M].北京:人民卫生出版社,2012:71-72.
[7] 张郭丽.Cook球囊联合雌孕激素在中重度宫腔粘连患者宫腔镜下冷刀术后的应用效果[J].中国实用医刊,2021,48(22):50-52.
[8] 贾 旺,陶丽丹.益肾活血方对全麻人工流产术后患者子宫恢复和宫腔粘连发生情况的影响[J].陕西中医,2021,42(8):1080-1083.
[9] 毛利云,朱 铮,王屹雯,等.补肾填精行气活血法治疗中重度宫腔粘连疗效研究[J].陕西中医,2020,41(12):1731-1734.
[10] 陈金鹏,张克霞,刘 毅,等.地黄化学成分和药理作用的研究进展[J].中草药,2021,52(6):1772-1784.
[11] 郝庆秀,王继峰,牛建昭,等.熟地等4味中药的植物雌激素作用的实验研究[J].中国中药杂志,2009,34(5):620-624.
[12] 罗克燕,杨丹莉,徐 敏.菟丝子总黄酮对排卵障碍大鼠下丘脑-垂体-卵巢轴性激素水平的影响[J].中国实验方剂学杂志,2013,19(13):258-260.
[13] 石振萍,蒋朝辉,梁 卿,等.枸杞多糖结构及药理作用研究进展[J].甘肃中医药大学学报,2021,38(2):90-95.
[14] 崔永霞,王利丽,孙孝亚,等.山茱萸环烯醚萜苷类成分的研究进展[J].中华中医药杂志,2021,36(5):2869-2874.
[15] 马艳春,吴文轩,胡建辉,等.当归的化学成分及药理作用研究进展[J].中医药学报,2022,50(1):111-114.
[16] Ge J,Chen Y,Yang H,et al.Expression and significance of estrogen receptor and progesterone receptor in endometrial tissue of patients with intrauterine adhesions[J].Gland Surgery,2021, 10(4):1478-1486.
[17] 徐 洁,刘 艳,郭遂群.雌激素受体及基质金属蛋白酶-9在宫腔粘连组织中的表达及意义[J].广东医学,2015,36(8):1222-1225.
[18] 杜艳芳,孙 燕.ER、PR和NF-κB在宫腔粘连子宫内膜组织中的表达及意义[J].广西医科大学学报,2016,33(4):580-583.
[19] 张 蕾,武志娟,张建伟.中药复方治疗肾虚证不孕症临床疗效的Meta分析[J].海南医学院学报,2022,28(14):1080-1087.
[20] 耿 健.归肾丸治疗肾虚型卵巢储备功能下降不孕症患者的效果[J].中国医药指南,2021,19(6):136-137.
[21] 周新艳.归肾丸加味治疗子宫内膜偏薄不孕症的临床效果观察[J].中国医药指南,2018,16(16):197-198.

相似文献/References:

[1]闫晓彤,朱 婷,章晓乐,等.补肾活血方联合补佳乐对宫腔粘连大鼠YAP1/TGF-β1信号通路的影响[J].陕西中医,2022,(8):987.[doi:DOI:10.3969/j.issn.1000-7369.2022.08.001]
 YAN Xiaotong,ZHU Ting,ZHANG Xiaole,et al.Effect of Bushen Huoxue decoction combined with Progynova on YAP1/TGF-β1 pathway in intrauterine adhesions rats[J].,2022,(12):987.[doi:DOI:10.3969/j.issn.1000-7369.2022.08.001]

备注/Memo

备注/Memo:
基金项目:广州中医药大学学科研究重点建设项目(XK2019010); 张玉珍全国名老中医药专家传承工作室建设项目[粤中医办函(2017)209号]
更新日期/Last Update: 2022-12-09